Cue Biopharma Inc (CUE) Stock Price, Quote, News & History

CUENASDAQ
$30.90
2.639.3%
At close: Sep 21, 5:00 PM EST
$29.05
0.782.76%
Pre-Market: 4:24 AM EST

Cue Biopharma (CUE) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-50.05M
Investing Cash Flow (TTM)
131.00K
Financing Cash Flow (TTM)
39.82M
Free Cash Flow (TTM)
-50.17M
Capital Expenditure (TTM)
-121.00K
Net Change in Cash (TTM)
-10.10M

Analyst Trends and Forecast

1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$210.59M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
3.73
PB Ratio (TTM)
97.36
Earnings Yield % (TTM)
-95.16%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.32

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$2.50M
Total Cash
$17.39M
Debt to Equity
1.33
Issuance of Debt (TTM)
-$2.50M
Repayment of Debt (TTM)
-$2.50M

Key Statistics

Open
-
Close
$30.90
Volume / Avg.
948.00 / 237.83K
Day Range
- - -
52 Wk Range
4.97 - 45.50
Market Cap
$211.03M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
48
Short Interest
4.6%
Days to Cover
1.76

About

Sector
Health Care
Industry
Biotechnology
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an an...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Cue Biopharma (CUE) stock?

A

You can purchase shares of Cue Biopharma (NASDAQ:CUE) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Cue Biopharma (CUE) stock?

A

Cue Biopharma has a consensus price target of $126.63.

Q

What is the current price for Cue Biopharma (CUE)?

A

The stock price for Cue Biopharma (NASDAQ: CUE) is $29.05 last updated September 23, 2026 at 4:24 AM EDT.

Q

Does Cue Biopharma (CUE) pay a dividend?

A

There are no upcoming dividends for Cue Biopharma.

Q

When is Cue Biopharma (NASDAQ:CUE) reporting earnings?

A

Cue Biopharma does not have any upcoming earnings scheduled.

Q

Is Cue Biopharma (CUE) going to split?

A

There is no upcoming split for Cue Biopharma.

Q

What sector and industry does Cue Biopharma (CUE) operate in?

A

Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.